Skip to Content

'
Kenneth V.I. Rolston, M.D.

Present Title & Affiliation

N/A

Education & Training

N/A

Board Certifications

1/1984 American Board of Internal Medicine, Subspecialty Boards in Infectious Disease
1/1979 American Board of Internal Medicine
7/1977 FLEX
1/1974 ECFMG

Experience/Service

Academic Appointments

Internist and Professor of Medicine, Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Selected Publications

Peer-Reviewed Original Research Articles

1. Rolston KV. Letter to the Editor : Regarding: Kraft S, Mackler E, Schlickman P, Welch K, DePestel DD (2011) Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Supp Care Cancer 19;1969-1974. Support Care Cancer 20(6):1117-8, 6/2012. e-Pub 3/4/2012. PMID: 22391592.
2. Tarrand JJ, LaSala PR, Han XY, Rolston KV, Kontoyiannis DP. Dimethyl sulfoxide enhances the effectiveness of skin antiseptics and reduces the contamination rates of blood cultures. J Clin Microbiol 50(5):1552-7, 5/2012. e-Pub 2/29/2012. PMCID: PMC3347107.
3. Rolston KV, Mahajan SN, Chemaly RF. Antimicrobial De-escalation in Cancer Patients. Infection 40(2):223-4; author reply 229-30, 4/2012. e-Pub 11/17/2011. PMID: 22090318.
4. Borchardt RA, Rolston KV. Urinary tract infection: Consistent therapy to reduce resistance. JAAPA 25(3):23, 29, 3/2012. PMID: 22514955.
5. Borchardt RA, Rolston KV. Antimicrobial stewardship: a proactive approach to combating resistance. JAAPA 25(2):22, 26, 2/2012. PMID: 22416550.
6. Pongas G, Hamilos G, Rolston KV, Kontoyiannis DP. Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): Diverse and impactful. Support Care Cancer 20(2):261-5, 2/2012. e-Pub 12/30/2010. PMID: 21191800.
7. Borchardt RA, Rolston KV. Battling influenza: universal vaccination is the primary weapon. JAAPA 25(1):27-8, 1/2012. PMID: 22384753.
8. Rolston KV, Mihu C, Tarrand JJ. Current Microbiology of Percutaneous Endoscopic Gastrostomy Tube (PEG-Tube) Insertion Site Infections in Patients with Cancer. Support Care Cancer 19(8):1267-71, 8/2011. e-Pub 5/8/2011. PMID: 21553315.
9. Al Akhrass F, Debiane L, Abdallah L, Best L, Mulanovich V, Rolston K, Kontoyiannis DP. Palatal mucormycosis in patients with hematologic malignancy and stem cell transplantation. Med Mycol 49(4):400-405, 5/2011. e-Pub 11/15/2010. PMID: 21077735.
10. Bhusal Y, Mihu CN, Tarrand JJ, Rolston KV. Incidence of fluoroquinolone-resistant and extended-spectrum ß-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States. Chemotherapy 57(4):335-8, 2011. e-Pub 9/6/2011. PMID: 21912115.

Abstracts

1. Mahajan SN, Chemaly RF, Rolston KVI. Ertapenem usage for documented infections at a comprehensive cancer center. 49th IDSA, 10/2011.
2. Bhusal Y, Mihu CN, Tarrand JJ, Rolston KV. Incidence of fluoroquinolone resistant and extended-spectrum-beta-lactamase (ESBL) producing Escherichia coli at a comprehensive cancer center in the United States. DoIM Research Retreat, 5/2011.
3. Zuniga J, Rolston KV, Adachi J. Neutropenic enterocolitis complicating taxane-based chemotherapy in cancer. 49th IDSA, 2011.

Book Chapters

1. Rolston KVI. Immunological Issues and Associated Infectious Complications. In: Survivorship Textbook. M. D. Anderson Cancer Center: Houston, TX. In Press.
2. Rolston KVI. Management of Bacterial Infectious Complications in Cancer Patients. In: Bacteria and Cancer. Ed(s) A.A. Khan. Springer. In Press.
3. Rolston KVI. Neutropenic Fever and Sepsis: Evaluation and Management. In: Management of Infectious Complications in Cancer Patients, 2nd. Ed(s) T.R. Zembower and V Stosor. Springer Science & Business: New York, 2012.
4. Rolston KVI and Bodey GP. Management of the Neutropenic Patient with Fever. In: Principles and Practice of Cancer Infectious Diseases. Ed(s) A. Safdar. Springer: New York, 2011.

Last updated: 7/15/2013